Latest Insider Transactions at Aerovate Therapeutics, Inc. (AVTE)
This section provides a real-time view of insider transactions for Aerovate Therapeutics, Inc. (AVTE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aerovate Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aerovate Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2025
|
Fairmount Funds Management LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,333,126
+41.26%
|
$11,998,134
$9.14 P/Share
|
|
May 16
2025
|
Tom Frohlich Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+50.0%
|
$42,000
$7.4 P/Share
|
|
Apr 28
2025
|
Ra Capital Management, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
1,062,326
+45.2%
|
-
|
|
Aug 01
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
1,507
+9.56%
|
$1,507
$1.74 P/Share
|
|
Jul 31
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
11,454
+47.33%
|
$11,454
$1.74 P/Share
|
|
Jun 17
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
928,110
+10.52%
|
$928,110
$1.67 P/Share
|
|
Jun 14
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,600
-100.0%
|
$265,000
$25.0 P/Share
|
|
Jun 14
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,600
+50.0%
|
$148,400
$14.59 P/Share
|
|
Jun 14
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
15,000
-74.92%
|
$375,000
$25.03 P/Share
|
|
Jun 14
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+42.83%
|
$30,000
$2.14 P/Share
|
|
Jun 13
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-51.72%
|
$144,000
$24.5 P/Share
|
|
Jun 13
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+34.09%
|
$12,000
$2.14 P/Share
|
|
May 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-21.14%
|
$84,000
$21.47 P/Share
|
|
May 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+29.41%
|
$8,000
$2.14 P/Share
|
|
May 16
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-93.54%
|
$210,000
$21.72 P/Share
|
|
May 16
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|
|
May 02
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,981
-100.0%
|
$41,601
$21.02 P/Share
|
|
May 01
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
11,357
-96.78%
|
$227,140
$20.37 P/Share
|
|
May 01
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|
|
Apr 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-29.8%
|
$88,000
$22.82 P/Share
|
|
Apr 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+35.55%
|
$4,000
$1.74 P/Share
|
|
Apr 17
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
6,853
-34.69%
|
$157,619
$23.15 P/Share
|
|
Apr 17
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
6,853
+45.7%
|
$13,706
$2.14 P/Share
|
|
Apr 16
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-72.46%
|
$240,000
$24.67 P/Share
|
|
Apr 16
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|
|
Apr 10
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
7,500
-49.68%
|
$202,500
$27.17 P/Share
|
|
Apr 10
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+44.22%
|
$15,000
$2.14 P/Share
|
|
Apr 09
2024
|
David S. Grayzel |
SELL
Open market or private sale
|
Indirect |
11,882
-45.03%
|
$332,696
$28.15 P/Share
|
|
Apr 01
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
12,495
-86.44%
|
$387,345
$31.23 P/Share
|
|
Apr 01
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
12,495
+46.36%
|
$24,990
$2.14 P/Share
|
|
Apr 01
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,300
-85.81%
|
$153,700
$29.44 P/Share
|
|
Apr 01
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+50.0%
|
$74,200
$14.59 P/Share
|
|
Apr 01
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,325
-72.03%
|
$103,075
$31.97 P/Share
|
|
Apr 01
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
3,325
+41.87%
|
$33,250
$10.61 P/Share
|
|
Apr 01
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-62.25%
|
$300,000
$30.46 P/Share
|
|
Apr 01
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|
|
Mar 28
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,000
-73.46%
|
$261,000
$29.5 P/Share
|
|
Mar 28
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+42.35%
|
$18,000
$2.14 P/Share
|
|
Mar 27
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
11,068
-89.55%
|
$298,836
$27.97 P/Share
|
|
Mar 27
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
11,068
+47.24%
|
$110,680
$10.61 P/Share
|
|
Mar 25
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,432
-72.67%
|
$96,096
$28.01 P/Share
|
|
Mar 25
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
3,432
+42.08%
|
$34,320
$10.61 P/Share
|
|
Mar 19
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,300
-73.92%
|
$137,800
$26.07 P/Share
|
|
Mar 19
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+50.0%
|
$74,200
$14.59 P/Share
|
|
Mar 18
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
35,057
-80.52%
|
$911,482
$26.11 P/Share
|
|
Mar 18
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
35,057
+38.5%
|
$210,342
$6.38 P/Share
|
|
Mar 18
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-39.09%
|
$182,000
$26.11 P/Share
|
|
Mar 18
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+29.1%
|
$7,000
$1.94 P/Share
|
|
Mar 13
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
2,016
-50.7%
|
$50,400
$25.02 P/Share
|
|
Mar 13
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
2,016
+33.64%
|
$4,032
$2.14 P/Share
|